FDA Puts 510(k) Review Training Enhancements On Hold, Awaits Final Reports

FDA says it has put planned enhancements to 510(k) reviewer training on hold until it sees the final results of its internal 510(k) program assessment and the Institute of Medicine's upcoming report on the pre-market clearance program.

More from Archive

More from Medtech Insight